20933413

Source:http://linkedlifedata.com/resource/pubmed/id/20933413

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:20933413	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:20933413	lifeskim:mentions	umls-concept:C1113688	lld:lifeskim
pubmed-article:20933413	lifeskim:mentions	umls-concept:C1415500	lld:lifeskim
pubmed-article:20933413	lifeskim:mentions	umls-concept:C0456387	lld:lifeskim
pubmed-article:20933413	lifeskim:mentions	umls-concept:C0243076	lld:lifeskim
pubmed-article:20933413	pubmed:issue	22	lld:pubmed
pubmed-article:20933413	pubmed:dateCreated	2010-10-19	lld:pubmed
pubmed-article:20933413	pubmed:abstractText	A new class of selective orexin 2 antagonist was identified among commercial products. Initial SAR was obtained using commercial derivatives only prior to starting ad hoc medicinal chemistry activities.	lld:pubmed
pubmed-article:20933413	pubmed:language	eng	lld:pubmed
pubmed-article:20933413	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20933413	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:20933413	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20933413	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20933413	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20933413	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:20933413	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:20933413	pubmed:month	Nov	lld:pubmed
pubmed-article:20933413	pubmed:issn	1464-3405	lld:pubmed
pubmed-article:20933413	pubmed:author	pubmed-author:MicheliFabriz...	lld:pubmed
pubmed-article:20933413	pubmed:author	pubmed-author:Di...	lld:pubmed
pubmed-article:20933413	pubmed:author	pubmed-author:PellacaniAnna...	lld:pubmed
pubmed-article:20933413	pubmed:author	pubmed-author:PozzanAlfonso...	lld:pubmed
pubmed-article:20933413	pubmed:author	pubmed-author:AntoliniMarin...	lld:pubmed
pubmed-article:20933413	pubmed:copyrightInfo	Copyright © 2010 Elsevier Ltd. All rights reserved.	lld:pubmed
pubmed-article:20933413	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:20933413	pubmed:day	15	lld:pubmed
pubmed-article:20933413	pubmed:volume	20	lld:pubmed
pubmed-article:20933413	pubmed:owner	NLM	lld:pubmed
pubmed-article:20933413	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:20933413	pubmed:pagination	6405-7	lld:pubmed
pubmed-article:20933413	pubmed:meshHeading	pubmed-meshheading:20933413...	lld:pubmed
pubmed-article:20933413	pubmed:meshHeading	pubmed-meshheading:20933413...	lld:pubmed
pubmed-article:20933413	pubmed:meshHeading	pubmed-meshheading:20933413...	lld:pubmed
pubmed-article:20933413	pubmed:meshHeading	pubmed-meshheading:20933413...	lld:pubmed
pubmed-article:20933413	pubmed:meshHeading	pubmed-meshheading:20933413...	lld:pubmed
pubmed-article:20933413	pubmed:meshHeading	pubmed-meshheading:20933413...	lld:pubmed
pubmed-article:20933413	pubmed:meshHeading	pubmed-meshheading:20933413...	lld:pubmed
pubmed-article:20933413	pubmed:meshHeading	pubmed-meshheading:20933413...	lld:pubmed
pubmed-article:20933413	pubmed:year	2010	lld:pubmed
pubmed-article:20933413	pubmed:articleTitle	2-Methyl-3-furanyl-4H-1,2,4-triazol-3-ylthioamides: a new class of selective orexin 2 antagonists.	lld:pubmed
pubmed-article:20933413	pubmed:affiliation	Neurosciences Centre of Excellence, GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy. fabrizio.micheli@aptuit.com	lld:pubmed
pubmed-article:20933413	pubmed:publicationType	Journal Article	lld:pubmed
http://linkedlifedata.com/r...	http://linkedlifedata.com/r...	pubmed-article:20933413	lld:chembl